SkyAI, Inc.
NASDAQ:STSSMedical - Instruments & Supplies
+$0.00 today
- Market cap
- $55.65M
- Beta
- 2.02
- P/E (TTM)
- 1.3
- EPS (TTM)
- $0.91
Volume 0.00M
Average 0.37M
STSS Net Income
Bottom-line profit, the starting point for calculating cash from operations.
SkyAI, Inc.NASDAQ: STSS
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns negative
Q1 FY2026 net income was -$86.24M, compared with $1.93M a year earlier. Trailing-twelve-month net income was -$358.5M. Over 3 fiscal years it compounded at +287.7% a year.
Context
- Net income amounted to 132439.5% of revenue in FY2025.
- Net income grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 1 analysts of $0 (+100.0%) for the fiscal year ending Dec 2026, a slowdown from the +2808.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$86.24M-49.4% QoQ
- Last fiscal yearDec 2025
- -$270.34M+2808.0% YoY
- LTMMar 2026
- -$358.5M+5514.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -4571.1% | — | — |
| 1 year | +2808.0% | +100.0% | -2708.0 pp |
| 3-year CAGR | +287.7% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (270.34M) USD
- Year-over-year change
- -2808.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (270.34M) | -2808.0% |
| FY2024 | 2024-12-31 | (9.3M) | +5.5% |
| FY2023 | 2023-12-31 | (9.84M) | -112.1% |
| FY2022 | 2022-12-31 | (4.64M) | +0.5% |
| FY2021 | 2021-12-31 | (4.66M) | — |
Net Income vs competitors
How STSS compares with its peers on the latest reported figures
- STSS's LTM Mar 2026 net income of $358.5M is the 2nd largest of the 10 companies compared; the peer median is $19.58M.
- Its year-over-year change of +5514.8% is the 2nd highest of 10, against a peer median of +21.8%.
- Net income amounts to 90325.9% of revenue for STSS, versus a peer median of 145.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $26.68B | +43056.2% | +1.1% | 519699.0% | |
| LTM Mar 2026 | $358.5M | +5514.8% | +287.7% | 90325.9% | |
| LTM Mar 2026 | $50.14M | +11.8% | -8.1% | 145.8% | |
| LTM Mar 2026 | $32.14M | -2.6% | -10.3% | 56386.0% | |
| LTM Mar 2026 | $21.76M | +31.3% | +35.2% | — | |
| LTM Mar 2026 | $19.58M | -41.2% | +3.2% | — | |
| LTM Mar 2026 | $14.21M | +21.8% | -0.1% | 13535.2% | |
| LTM Mar 2026 | $12M | +28.1% | +25.2% | 16.1% | |
| LTM Mar 2026 | $9.77M | -2.7% | +25.7% | 7.9% | |
| LTM Mar 2026 | $2.31M | +126.6% | +66.8% | 4.1% | |
| Peer median (excluding STSS) | $19.58M | +21.8% | +3.2% | 145.8% | |
Competitors are the stored peer set for STSS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (4.66M) | (4.64M) | (9.84M) | (9.3M) | (270.34M) |
| Depreciation & Amortization | 28.7K | 654.57K | 882.18K | 773.9K | 132.54K |
| Deferred Income Tax | 0 | 0 | (30K) | (30K) | 0 |
| Stock-Based Compensation | 1.2M | 1.01M | 963.02K | 520.83K | 107.47M |
| Change in Working Capital | 112.64K | (209.22K) | (1.12M) | (426.18K) | 2.79M |
| Accounts Receivables | 0 | 0 | 0 | 0 | (204.12K) |
| Inventory | (121.99K) | (34.11K) | (1.44M) | (350.56K) | (298.24K) |
| Accounts Payables | 202.89K | (104.35K) | 415.51K | 11.94K | 238.45K |
| Other Working Capital | 31.74K | (70.75K) | (94.9K) | (87.56K) | 3.05M |
| Other Non-Cash Items | 179.52K | (3.25M) | 639.99K | 1.53M | 143.23M |
| Operating Cash Flow | (3.15M) | (6.43M) | (8.51M) | (6.93M) | (16.72M) |
| Capital Expenditures | (2.27M) | (752.34K) | (698.28K) | (138.8K) | 3 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (209.68K) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (75K) | (2.16M) | 0 | (1.02M) | (18.64M) |
| Investing Cash Flow | (2.34M) | (3.12M) | (698.28K) | (1.16M) | (189.16M) |
| Debt Repayment | 1.8M | (2M) | 0 | 2.53M | 3.41M |
| Common Stock Issued | 3.38M | 14.2M | 8.03M | 3.37M | 212.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 32.5K | 0 | 0 | 0 |
| Financing Cash Flow | 5.18M | 12.24M | 8.03M | 5.91M | 215.51M |
| Effect of Forex Changes | 0 | 7.33K | 17.96K | 36.41K | (250K) |
| Net Change in Cash | (311.04K) | 2.69M | (1.16M) | (2.15M) | 9.38M |
| Free Cash Flow | (5.42M) | (7.19M) | (9.21M) | (7.07M) | (16.72M) |
SkyAI, Inc.
NASDAQ:STSS
Intrinsic Alpha fair value
Locked
Current Price
$1.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.